KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer
Clinical trial NCT03847168 · UNKNOWN
Trial details
- NCT number
- NCT03847168
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2022-12-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.